Veterinary Medicines

AMOXYN 100 % tirpūs geriamieji milteliai

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
AMOXYN 100 % tirpūs geriamieji milteliai
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Chicken
  • Turkey
  • Pig
Route of administration:
  • In drinking water use
  • In-feed use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat
        3
        day
    • Turkey
      • Meat
        3
        day
    • Pig
      • Meat
        3
        day
  • In-feed use
    • Pig
      • Meat
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Pharmaceuticals Ltd.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/01/1338/001-003
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 18/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."